Company: DVAX
Filing Date: 2025-04-15
Form Type: PRER14A
Source: 0000930413-25-001254
Chunk: 76

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-15
Form: PRER14A
Chunk 76
---
-----|:----|:--------------|:----|---------------------:|:----|:------------------|------:|:----|:-------------------|----------:|:----|:-----------|
| Ryan Spencer         |     | 2/15/2024     |     |              231,000 |     | $                 | 12.48 |     | $                  | 1,824,299 |     | 2.5%       |
| Kelly MacDonald      |     | 2/15/2024     |     |               65,000 |     | $                 | 12.48 |     | $                  |   513,331 |     | 2.5%       |
| David F. Novack      |     | 2/15/2024     |     |               95,000 |     | $                 | 12.48 |     | $                  |   750,253 |     | 2.5%       |
| John L. Slebir       |     | 2/15/2024     |     |               70,000 |     | $                 | 12.48 |     | $                  |   552,818 |     | 2.5%       |
| Robert Janssen, M.D. |     | 2/15/2024     |     |               50,000 |     | $                 | 12.48 |     | $                  |   394,870 |     | 2.5%       |

| (1) | These stock option awards were granted at a regularly scheduled meeting of the Compensation Committee.                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| (2) | This represents the percentage change in the closing market price of the common stock between the trading day ending immediately prior to the disclosure of material nonpublic information (February 22, 2024) and the trading day beginning immediately following the disclosure of material nonpublic information (February 23, 2024). On February 22, 2024, we filed our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and a current report on Form 8-K related to our financial results for the fourth quarter and fiscal year ended December 31, 2023. |

| 62 |

We encourage our NEOs to hold a significant equity
interest in our Company, but we have not set specific stock ownership guidelines.

Compensation Recovery Policy